Autoimmune Disease Testing Market Size, Share & COVID-19 Impact Analysis, By Product Type (Instruments and Reagents & Consumables), By Disease Type (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Scleroderma, Vasculitis, Inflammatory Bowel Disease, and Others), By Test Type (Antinuclear Autoantibody, Rheumatoid Factor, C-Reactive Protein, Anti-Thyroglobulin Antibody, and Others), By End-user (Hospital & Clinics, Diagnostic Centers, and Others), and Regional Forecast, 2026-2034

Last Updated: March 09, 2026 | Format: PDF | Report ID: FBI104460

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Key Autoimmune Diseases, By Key Countries/Regions, 2025
2. New Product Launches, By Key Players
3. Key Industry Developments -Mergers, Acquisitions and Partnerships
4. Technological Advancements in Testing Products
5. Impact of COVID-19 on the Market
Global Autoimmune Disease Testing Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product Type
  1. Instruments
  2. Reagents & Consumables
2. Market Analysis, Insights and Forecast – By Disease Type
  1. Rheumatoid Arthritis (RA)
  2. Systemic Lupus Erythematosus (SLE)
  3. Scleroderma
  4. Vasculitis
  5. Inflammatory Bowel Disease (IBD)
  6. Others
3. Market Analysis, Insights and Forecast – By Test Type
  1. Antinuclear Autoantibody (ANA)
  2. Rheumatoid Factor (RF)
  3. C-Reactive Protein (CRP)
  4. Anti-Thyroglobulin Antibody (ATA)
  5. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospital & Clinics
  2. Diagnostic Centers
  3. Others
5. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Autoimmune Disease Testing Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product Type
  1. Instruments
  2. Reagents & Consumables
2. Market Analysis, Insights and Forecast – By Disease Type
  1. Rheumatoid Arthritis (RA)
  2. Systemic Lupus Erythematosus (SLE)
  3. Scleroderma
  4. Vasculitis
  5. Inflammatory Bowel Disease (IBD)
  6. Others
3. Market Analysis, Insights and Forecast – By Test Type
  1. Antinuclear Autoantibody (ANA)
  2. Rheumatoid Factor (RF)
  3. C-Reactive Protein (CRP)
  4. Anti-Thyroglobulin Antibody (ATA)
  5. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospital & Clinics
  2. Diagnostic Centers
  3. Others
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Autoimmune Disease Testing Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product Type
  1. Instruments
  2. Reagents & Consumables
2. Market Analysis, Insights and Forecast – By Disease Type
  1. Rheumatoid Arthritis (RA)
  2. Systemic Lupus Erythematosus (SLE)
  3. Scleroderma
  4. Vasculitis
  5. Inflammatory Bowel Disease (IBD)
  6. Others
3. Market Analysis, Insights and Forecast – By Test Type
  1. Antinuclear Autoantibody (ANA)
  2. Rheumatoid Factor (RF)
  3. C-Reactive Protein (CRP)
  4. Anti-Thyroglobulin Antibody (ATA)
  5. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospital & Clinics
  2. Diagnostic Centers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. U.K.
  2. Germany
  3. France
  4. Italy
  5. Spain
  6. Rest of Europe
Asia Pacific Autoimmune Disease Testing Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product Type
  1. Instruments
  2. Reagents & Consumables
2. Market Analysis, Insights and Forecast – By Disease Type
  1. Rheumatoid Arthritis (RA)
  2. Systemic Lupus Erythematosus (SLE)
  3. Scleroderma
  4. Vasculitis
  5. Inflammatory Bowel Disease (IBD)
  6. Others
3. Market Analysis, Insights and Forecast – By Test Type
  1. Antinuclear Autoantibody (ANA)
  2. Rheumatoid Factor (RF)
  3. C-Reactive Protein (CRP)
  4. Anti-Thyroglobulin Antibody (ATA)
  5. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospital & Clinics
  2. Diagnostic Centers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Rest of Asia Pacific
Rest of the World Autoimmune Disease Testing Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product Type
  1. Instruments
  2. Reagents & Consumables
2. Market Analysis, Insights and Forecast – By Disease Type
  1. Rheumatoid Arthritis (RA)
  2. Systemic Lupus Erythematosus (SLE)
  3. Scleroderma
  4. Vasculitis
  5. Inflammatory Bowel Disease (IBD)
  6. Others
3. Market Analysis, Insights and Forecast – By Test Type
  1. Antinuclear Autoantibody (ANA)
  2. Rheumatoid Factor (RF)
  3. C-Reactive Protein (CRP)
  4. Anti-Thyroglobulin Antibody (ATA)
  5. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospital & Clinics
  2. Diagnostic Centers
  3. Others
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. Siemens Healthcare GmbH
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  2. Thermo Fisher Scientific Inc.
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  3. Quest Diagnostics Incorporated
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  4. Abbott
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  5. Werfen
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  6. Trinity Biotech
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  7. F. Hoffmann-La Roche Ltd
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  8. Bio-Rad Laboratories, Inc.
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Key Autoimmune Diseases, By Key Countries/Regions, 2025
2. New Product Launches, By Key Players
3. Key Industry Developments -Mergers, Acquisitions and Partnerships
4. Technological Advancements in Testing Products
5. Impact of COVID-19 on the Market
Global Autoimmune Disease Testing Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product Type
  1. Instruments
  2. Reagents & Consumables
2. Market Analysis, Insights and Forecast – By Disease Type
  1. Rheumatoid Arthritis (RA)
  2. Systemic Lupus Erythematosus (SLE)
  3. Scleroderma
  4. Vasculitis
  5. Inflammatory Bowel Disease (IBD)
  6. Others
3. Market Analysis, Insights and Forecast – By Test Type
  1. Antinuclear Autoantibody (ANA)
  2. Rheumatoid Factor (RF)
  3. C-Reactive Protein (CRP)
  4. Anti-Thyroglobulin Antibody (ATA)
  5. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospital & Clinics
  2. Diagnostic Centers
  3. Others
5. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Autoimmune Disease Testing Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product Type
  1. Instruments
  2. Reagents & Consumables
2. Market Analysis, Insights and Forecast – By Disease Type
  1. Rheumatoid Arthritis (RA)
  2. Systemic Lupus Erythematosus (SLE)
  3. Scleroderma
  4. Vasculitis
  5. Inflammatory Bowel Disease (IBD)
  6. Others
3. Market Analysis, Insights and Forecast – By Test Type
  1. Antinuclear Autoantibody (ANA)
  2. Rheumatoid Factor (RF)
  3. C-Reactive Protein (CRP)
  4. Anti-Thyroglobulin Antibody (ATA)
  5. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospital & Clinics
  2. Diagnostic Centers
  3. Others
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Autoimmune Disease Testing Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product Type
  1. Instruments
  2. Reagents & Consumables
2. Market Analysis, Insights and Forecast – By Disease Type
  1. Rheumatoid Arthritis (RA)
  2. Systemic Lupus Erythematosus (SLE)
  3. Scleroderma
  4. Vasculitis
  5. Inflammatory Bowel Disease (IBD)
  6. Others
3. Market Analysis, Insights and Forecast – By Test Type
  1. Antinuclear Autoantibody (ANA)
  2. Rheumatoid Factor (RF)
  3. C-Reactive Protein (CRP)
  4. Anti-Thyroglobulin Antibody (ATA)
  5. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospital & Clinics
  2. Diagnostic Centers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. U.K.
  2. Germany
  3. France
  4. Italy
  5. Spain
  6. Rest of Europe
Asia Pacific Autoimmune Disease Testing Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product Type
  1. Instruments
  2. Reagents & Consumables
2. Market Analysis, Insights and Forecast – By Disease Type
  1. Rheumatoid Arthritis (RA)
  2. Systemic Lupus Erythematosus (SLE)
  3. Scleroderma
  4. Vasculitis
  5. Inflammatory Bowel Disease (IBD)
  6. Others
3. Market Analysis, Insights and Forecast – By Test Type
  1. Antinuclear Autoantibody (ANA)
  2. Rheumatoid Factor (RF)
  3. C-Reactive Protein (CRP)
  4. Anti-Thyroglobulin Antibody (ATA)
  5. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospital & Clinics
  2. Diagnostic Centers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Rest of Asia Pacific
Rest of the World Autoimmune Disease Testing Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product Type
  1. Instruments
  2. Reagents & Consumables
2. Market Analysis, Insights and Forecast – By Disease Type
  1. Rheumatoid Arthritis (RA)
  2. Systemic Lupus Erythematosus (SLE)
  3. Scleroderma
  4. Vasculitis
  5. Inflammatory Bowel Disease (IBD)
  6. Others
3. Market Analysis, Insights and Forecast – By Test Type
  1. Antinuclear Autoantibody (ANA)
  2. Rheumatoid Factor (RF)
  3. C-Reactive Protein (CRP)
  4. Anti-Thyroglobulin Antibody (ATA)
  5. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospital & Clinics
  2. Diagnostic Centers
  3. Others
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. Siemens Healthcare GmbH
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  2. Thermo Fisher Scientific Inc.
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  3. Quest Diagnostics Incorporated
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  4. Abbott
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  5. Werfen
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  6. Trinity Biotech
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  7. F. Hoffmann-La Roche Ltd
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  8. Bio-Rad Laboratories, Inc.
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)

Read Less

List of Figures

Figure 01: Global Autoimmune Disease Testing Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034

Figure 02: Global Autoimmune Disease Testing Market Value Share (%), By Product Type, 2025 & 2034

Figure 03: Global Autoimmune Disease Testing Market Value Share (%), By Disease Type, 2025 & 2034

Figure 04: Global Autoimmune Disease Testing Market Value Share (%), By Test Type, 2025 & 2034

Figure 05: Global Autoimmune Disease Testing Market Value Share (%), By End-user, 2025 & 2034

Figure 06: Global Autoimmune Disease Testing Market Value Share (%), By Region, 2025 & 2034

Figure 07: North America Autoimmune Disease Testing Market Value (USD billion), by Product Type, 2025 & 2034

Figure 08: North America Autoimmune Disease Testing Market Value Share (%), by Product Type, 2025

Figure 09: North America Autoimmune Disease Testing Market Value (USD billion), by Disease Type, 2025 & 2034

Figure 10: North America Autoimmune Disease Testing Market Value Share (%), by Disease Type, 2025

Figure 11: North America Autoimmune Disease Testing Market Value (USD billion), by Test Type, 2025 & 2034

Figure 12: North America Autoimmune Disease Testing Market Value Share (%), by Test Type, 2025

Figure 13: North America Autoimmune Disease Testing Market Value (USD billion), by End-user, 2025 & 2034

Figure 14: North America Autoimmune Disease Testing Market Value Share (%), by End-user, 2025

Figure 15: North America Autoimmune Disease Testing Market Value (USD billion), by Country, 2025 & 2034

Figure 16: North America Autoimmune Disease Testing Market Value Share (%), by Country, 2025

Figure 17: Europe Autoimmune Disease Testing Market Value (USD billion), by Product Type, 2025 & 2034

Figure 18: Europe Autoimmune Disease Testing Market Value Share (%), by Product Type, 2025

Figure 19: Europe Autoimmune Disease Testing Market Value (USD billion), by Disease Type, 2025 & 2034

Figure 20: Europe Autoimmune Disease Testing Market Value Share (%), by Disease Type, 2025

Figure 21: Europe Autoimmune Disease Testing Market Value (USD billion), by Test Type, 2025 & 2034

Figure 22: Europe Autoimmune Disease Testing Market Value Share (%), by Test Type, 2025

Figure 23: Europe Autoimmune Disease Testing Market Value (USD billion), by End-user, 2025 & 2034

Figure 24: Europe Autoimmune Disease Testing Market Value Share (%), by End-user, 2025

Figure 25: Europe Autoimmune Disease Testing Market Value (USD billion), by Country/Sub-region, 2025 & 2034

Figure 26: Europe Autoimmune Disease Testing Market Value Share (%), by Country/Sub-region, 2025

Figure 27: Asia Pacific Autoimmune Disease Testing Market Value (USD billion), by Product Type, 2025 & 2034

Figure 28: Asia Pacific Autoimmune Disease Testing Market Value Share (%), by Product Type,

Figure 29: Asia Pacific Autoimmune Disease Testing Market Value (USD billion), by Disease Type, 2025 & 2034

Figure 30: Asia Pacific Autoimmune Disease Testing Market Value Share (%), by Disease Type, 2025

Figure 31: Asia Pacific Autoimmune Disease Testing Market Value (USD billion), by Test Type, 2025 & 2034

Figure 32: Asia Pacific Autoimmune Disease Testing Market Value Share (%), by Test Type, 2025

Figure 33: Asia Pacific Autoimmune Disease Testing Market Value (USD billion), by End-user, 2025 & 2034

Figure 34: Asia Pacific Autoimmune Disease Testing Market Value Share (%), by End-user, 2025

Figure 35: Asia Pacific Autoimmune Disease Testing Market Value (USD billion), by Country/Sub-region, 2025 & 2034

Figure 36: Asia Pacific Autoimmune Disease Testing Market Value Share (%), by Country/Sub-region, 2025

Figure 37: Rest of the World Autoimmune Disease Testing Market Value (USD billion), by Product Type, 2025 & 2034

Figure 38: Rest of the World Autoimmune Disease Testing Market Value Share (%), by Product Type, 2025

Figure 39: Rest of the World Autoimmune Disease Testing Market Value (USD billion), by Disease Type, 2025 & 2034

Figure 40: Rest of the World Autoimmune Disease Testing Market Value Share (%), by Disease Type, 2025

Figure 41: Rest of the World Autoimmune Disease Testing Market Value (USD billion), by Test Type, 2025 & 2034

Figure 42: Rest of the World Autoimmune Disease Testing Market Value Share (%), by Test Type, 2025

Figure 43: Rest of the World Autoimmune Disease Testing Market Value (USD billion), by End-user, 2025 & 2034

Figure 44: Rest of the World Autoimmune Disease Testing Market Value Share (%), by End-user, 2025

Figure 45: Figure 45: Global Autoimmune Disease Testing Market Share (%), 2025

List of Tables

Table 01: Global Autoimmune Disease Testing Market Revenue (USD billion) Forecast, By Product Type, 2021–2034

Table 02: Global Autoimmune Disease Testing Market Revenue (USD billion) Forecast, By Disease Type, 2021–2034

Table 03: Global Autoimmune Disease Testing Market Revenue (USD billion) Forecast, By Test Type, 2021–2034

Table 04: Global Autoimmune Disease Testing Market Revenue (USD billion) Forecast, By End-user, 2021–2034

Table 05: Global Autoimmune Disease Testing Market Revenue (USD billion) Forecast, By Region, 2021–2034

Table 06: North America Autoimmune Disease Testing Market Revenue (USD billion) Forecast, By Product Type, 2021–2034

Table 07: North America Autoimmune Disease Testing Market Revenue (USD billion) Forecast, By Disease Type, 2021–2034

Table 08: North America Autoimmune Disease Testing Market Revenue (USD billion) Forecast, By Test Type, 2021–2034

Table 09: North America Autoimmune Disease Testing Market Revenue (USD billion) Forecast, By End-user, 2021–2034

Table 10: North America Autoimmune Disease Testing Market Revenue (USD billion) Forecast, By Country, 2021–2034

Table 11: Europe Autoimmune Disease Testing Market Revenue (USD billion) Forecast, By Product Type, 2021–2034

Table 12: Europe Autoimmune Disease Testing Market Revenue (USD billion) Forecast, By Disease Type, 2021–2034

Table 13: Europe Autoimmune Disease Testing Market Revenue (USD billion) Forecast, By Test Type, 2021–2034

Table 14: Europe Autoimmune Disease Testing Market Revenue (USD billion) Forecast, By End-user, 2021–2034

Table 15: Europe Autoimmune Disease Testing Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021–2034

Table 16: Asia Pacific Autoimmune Disease Testing Market Revenue (USD billion) Forecast, By Product Type, 2021–2034

Table 17: Asia Pacific Autoimmune Disease Testing Market Revenue (USD billion) Forecast, By Disease Type, 2021–2034

Table 18: Asia Pacific Autoimmune Disease Testing Market Revenue (USD billion) Forecast, By Test Type, 2021–2034

Table 19: Asia Pacific Autoimmune Disease Testing Market Revenue (USD billion) Forecast, By End-user, 2021–2034

Table 20: Asia Pacific Autoimmune Disease Testing Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021–2034

Table 21: Rest of the World Autoimmune Disease Testing Market Revenue (USD billion) Forecast, By Product Type, 2021–2034

Table 22: Rest of the World Autoimmune Disease Testing Market Revenue (USD billion) Forecast, By Disease Type, 2021–2034

Table 23: Rest of the World Autoimmune Disease Testing Market Revenue (USD billion) Forecast, By Test Type, 2021–2034

Table 24: Rest of the World Autoimmune Disease Testing Market Revenue (USD billion) Forecast, By End-user, 2021–2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2021
NO OF PAGES: 150

Buy Now

Download Free Sample

Security Code

Get 20% Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

(APAC) +91 744 740 1245
sales@fortunebusinessinsights.com